MedTrace Logo

Treating Post-Lyme Disease Syndrome With Acetogenins

NCT04078841 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-02-11

No results posted yet for this study

Summary

To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).

Conditions

  • Post-Lyme Disease Syndrome (PLDS)

Interventions

DIETARY_SUPPLEMENT

ReaLife+ (RLP)

RLP is a dietary supplement containing Acetogenins, vitamin, mineral and amino acids.

OTHER

Inert Brown powder

Brown powder Inert brown powder to look similar to RLP

Sponsors & Collaborators

  • Optimal Health Research

    lead OTHER

Principal Investigators

  • Dr Jeppsen, MD · IRB Chair

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2019-11-14
Completion
2020-01-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04078841 on ClinicalTrials.gov